Principaux concurrents
Rendement du dividende (N) Rendement du dividende (N+1) PER (N) Price to Book (N) VE / CA (N) VE / EBITDA (N) VE / EBIT (N) Capi.($)
- - - - - - - 10,71 M
1,5%1,7%21.25x4.11x6.51x14.24x16.4x 56,7 Md
0,05%0,09%31.6x6x7.8x24.02x24.51x 51,97 Md
-.--%-.--%-17.91x1.1x4.18x-7.32x-6.17x 23,33 Md
-.--%-.--%-38.06x49.84x12.21x-36.05x-39.76x 21,34 Md
-.--%-.--%24.28x2.75x4.73x15.36x17.32x 17,44 Md
0,09%0,14%40.7x10.44x16.37x42.16x38.68x 14,77 Md
-.--%-.--%16.73x4.75x4.82x11.24x12.14x 13,84 Md
-.--%-.--%-26.07x28.14x24.96x-31.27x-24.97x 12,12 Md
-.--%-.--%-74.01x24.05x6.75x-55.74x-54.56x 11,14 Md
-.--%-.--%-12.07x-83.8x87.58x-13.65x-13.27x 10,38 Md
-.--%-.--%-10.72x38.23x2390.94x-12.67x-11.01x 10,41 Md
-.--%-.--%-32x8.79x - -29.57x-28.61x 8,35 Md
-.--%-.--%-6.35x - - -6.51x-5.99x 7,73 Md
0,41%0,48%18.16x5.14x - - - 7,05 Md
0,16%0,23%51.51x1.84x3.97x17.88x33.18x 7,26 Md
-.--%-.--%-17.06x19.97x666.31x-18.82x-15.89x 6,64 Md
Moyenne 0,14% 0,16% -1,88x 8,09x 249,01x -5,78x -3,87x 16,5 Md
Moyenne pondérée par Capi. 0,33% 0,39% 5,59x 8,41x 124,93x 2,18x 3,44x
Médicaments bio-thérapeutiques